8th Annual Blueprint for Breakthrough Forum Validating Real-World Endpoints for an Evolving Regulatory Landscape Thank you to all who attended! Click HERE for access to the meeting whitepaper and check our Engaging Innovation blog soon for a full event recap. Featuring Keynotes from: Dr. Ned Sharpless Acting Commissioner, U.S. FDA & Dr. Amy…
7th Annual Blueprint for Breakthrough Forum Research and Reimbursement in the Age of Precision Medicine September 13, 2018 The Four Seasons 2800 Pennsylvania Ave NW, Washington, DC 20007 8:30AM – 1:00PM EDT Thank you to all that attended our event! To access the meeting white paper, please Click HERE, and check our Engaging Innovation…
To access a meeting recap of this archived event, please Click HERE. Molecularly Targeted Therapies in Pediatric Cancer Tuesday, February 20, 2018 8:00 AM EST – 1:00 PM EST JW Marriott 1331 Pennsylvania Ave NW Salon DE Washington, DC 20004 Thank you to all attendees! Click HERE for the finalized meeting…
A Blueprint for Breakthrough – Charting the Course for Precision Medicine September 13, 2017 Marriott Marquis Hotel 901 Massachusetts Ave NW, Washington, DC 20001 Thank you to all that attended. To access a full recap, including links to relevant papers, videos, and presentations, Click HERE. Join us on September 13, 2017, as Friends…
Accelerating Pediatric Drug Development A Friends of Cancer Research Forum On Tuesday, February 21, 2017, Friends of Cancer Research (Friends) hosted the Accelerating Pediatric Drug Development forum at the Washington Marriott. The half-day forum brought together clinicians, advocates, academics, and regulators to discuss how best to accelerate pediatric drug development. Our goal is simple: we…
The Future of the U.S. Biosimilars Market: Development, Education, and Utilization Tuesday, October 18, 2016 – 9:00am – 1:00pm Ritz-Carlton (Venue Change) 1150 22nd St NW Washington, DC Salon 1 & 2 On October 18, 2016, Friends of Cancer Research (Friends) and the Duke-Margolis Center for Health Policy held a…
Friends of Cancer Research and the Parker Institute for Cancer Immunotherapy convened a roundtable discussion on October 5, 2016, to discuss strategies to optimize the use of immunotherapy in cancer. Leading experts in the field shared their perspective on the state of the field and strategies to address current research questions and evidence gaps. The…
Exploring Use of Real World Evidence in Clinical Trials: A Recap from the 2016 Blueprint for Breakthrough Forum This year marked the 5th annual Alexandria Summit and Friends of Cancer Research Blueprint for Breakthrough Forum, with this year’s focus being the potential utility of Real World Evidence (RWE) in clinical trials. There were three panels…
A Blueprint for Drug/Diagnostic Co-Development: Genetic Databases September 9th, 2015 – 9:00am-12:00pm The Mayflower 1127 Connecticut Ave NW Washington, DC 20036 Friends of Cancer Research and Alexandria Summit/Alexandria Venture Investments will convene researchers, sponsors, advocates, and regulators for our annual forum addressing challenges in the co-development of drugs and companion diagnostics. Two expert panels will discuss…
A Friends of Cancer Research roundtable with: Dr. Robert Califf Deputy Commissioner for Medical Products and Tobacco U.S. Food and Drug Administration Tuesday May 19, 2015 – 9:00am – 12:00pm The West Health Policy Center – 1909 K St NW, Washington, DC A forum for leaders of disease and health advocacy organizations, industry, trade associations,…
